National Disease Research Interchange
- Assets
- $6.9m
- Revenue
- $7.4m
- Investments
- $0.0
- Employees
- 44
- Location
- Philadelphia, PA
- Founding
- 08/1982
- Data as of
- 12/2022
- EIN
- 23-2213205
Organization Overview
National Disease Research Interchange is located in Philadelphia, PA. The organization was established in 1982. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2022, National Disease Research Interchange employed 44 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. National Disease Research Interchange is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, National Disease Research Interchange generated $7.4m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 8 years, the organization has seen revenues fall by an average of (5.0%) each year. All expenses for the organization totaled $8.1m during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (2.7%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
ADVANCING THE PROCUREMENT, PRESERVATION AND DISTRIBUTION OF HUMAN CELLS, TISSUES AND ORGANS FOR BIOMEDICAL RESEARCH, NATIONALLY AND INTERNATIONALLY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
HUMAN TISSUE AND RESOURCE FOR RESEARCH: NDRI RECEIVED A FEDERAL AWARD FOR THE HUMAN TISSUE AND ORGAN RESOURCE FOR THE PROCUREMENT AND DISTRIBUTION OF NORMAL AND DISEASED HUMAN ORGANS AND TISSUES TO ADVANCE BIOMEDICAL SCIENCE.
PARTNER PROGRAM: COORDINATES VARIOUS HUMAN ORGAN AND TISSUE PROCUREMENT PROGRAMS WITH THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO ACCELERATE RESEARCH AND DEVELOPMENT. SEVERAL OF THESE PROGRAMS HAVE LED TO THE DEVELOPMENT OF TREATMENTS FOR MEDICAL CONDITIONS SUCH AS LUNG DISEASE, DIABETES, AND CANCER, TO NAME ONLY A FEW. OTHER PARTNER PROGRAMS HAVE LED TO THE CREATION OF RESEARCH TOOLS FOR USE IN NUMEROUS TOXICOLOGY AND DRUG DISCOVERY PLATFORMS.
RESEARCH COLLABORATIONS WITH FOUNDATION AND PATIENT ADVOCACY GROUPS (PAG): NDRI MAINTAINS COLLABORATIONS WITH A VARIETY OF DIFFERENT FOUNDATION AND PATIENT ADVOCACY GROUPS FOCUSED ON THE ADVANCEMENT OF RESEARCH IN EACH OF THEIR RESPECTIVE AREAS OF INTEREST. THESE COLLABORATIONS BRING TOGETHER PATIENTS, PAGS, FOUNDATIONS, NDRI AND THE PHARMACEUTICAL INDUSTRY TO HELP ADVANCE R&D UTILIZING CRITICAL HUMAN BIOSPECIMENS GIFTED BY PATIENTS/DONORS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
William Leinweber President & CEO | OfficerTrustee | 37.5 | $383,238 |
Mary Jc Hendrix Chair Of The Board | OfficerTrustee | 1 | $0 |
David M Albert Board Member | Trustee | 1 | $0 |
Shawn Blackburn Board Member | Trustee | 1 | $0 |
Sulayman Dib-Hajj Board Member | Trustee | 1 | $0 |
Megan Kasimatis Singleton Board Member | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Connectlife (Upstate New York Transplant Organ/tissue Procurement | 12/30/22 | $290,075 |
Children's Hospital Of Philadelphia Rese Dgtex Subcontract Services | 12/30/22 | $267,286 |
Center For Organ Recovery & Education Organ/tissue Procurement | 12/30/22 | $208,125 |
University Of Maryland Baltimore Dgtex Subcontract Services | 12/30/22 | $158,567 |
Ancero Llc It Consulting Services | 12/30/22 | $134,008 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $144,760 |
| Related organizations | $0 |
| Government grants | $3,164,233 |
| All other contributions, gifts, grants, and similar amounts not included above | $355 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $3,309,348 |
| Total Program Service Revenue | $4,156,336 |
| Investment income | $15,922 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | -$79,091 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $7,402,515 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $704,868 |
| Compensation of current officers, directors, key employees. | $704,868 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $2,041,012 |
| Pension plan accruals and contributions | $44,127 |
| Other employee benefits | $194,387 |
| Payroll taxes | $128,400 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $281,140 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $18,775 |
| Advertising and promotion | $139,201 |
| Office expenses | $0 |
| Information technology | $246,220 |
| Royalties | $0 |
| Occupancy | $250,597 |
| Travel | $99,999 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $906,342 |
| Insurance | $69,329 |
| All other expenses | $454,136 |
| Total functional expenses | $8,132,656 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $500 |
| Savings and temporary cash investments | $1,131,037 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $1,997,642 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $44,910 |
| Prepaid expenses and deferred charges | $107,800 |
| Net Land, buildings, and equipment | $1,724,260 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $1,901,966 |
| Total assets | $6,908,115 |
| Accounts payable and accrued expenses | $736,959 |
| Grants payable | $0 |
| Deferred revenue | $2,263 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $1,150,596 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $3,095,537 |
| Total liabilities | $4,985,355 |
| Net assets without donor restrictions | $1,922,760 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $6,908,115 |